Keywords
Clopidogrel
Triacylglycerol
Total cholesterol
Submitted : 2023-02-26
Accepted : 2023-03-13
Published : 2023-03-28
Abstract
Objective: To explore the clinical value of clopidogrel as the main treatment for patients with unstable angina. Methods: From January 2020 to December 2022, we assigned 50 cases to the control group (basic treatment) and 50 cases to the observation group (basic treatment with clopidogrel). The clinical data of both groups of patients were analyzed. Results: The total effective rate of the observation group was significantly higher than that of the control group after treatment (P < 0.05). Before treatment, there were no significant differences in the duration of angina pectoris and frequency of attacks between the two groups (P > 0.05); after treatment, the duration of angina pectoris and frequency of attacks in the observation group were significantly lower than those in the control group (P < 0.05). Before treatment, there were no significant differences in hemorheological indices, triacylglycerol (TG), total cholesterol (TC), and platelet aggregation rate between the two groups (P > 0.05); however, after treatment, they were significantly lower in the observation group than in the control group (P < 0.05). Before treatment, there was no significant difference in the scores of SF-36 between the two groups (P > 0.05); after treatment, the SF-36 score of the observation group was significantly higher than that of the control group (P < 0.05). Conclusion: Clopidogrel can promote the rehabilitation of patients with unstable angina during treatment. Compared with conventional basic treatment, it can reinforce the final therapeutic effect. In addition, our study showed that the duration of angina pectoris and the frequency of attacks were shortened after clopidogrel therapy and the treatment had an effect on improving patients’ hemorheological indices, TG, TC, and platelet aggregation rate. Clopidogrel therapy plays an important role in ensuring the quality of life of patients after recovery.
References
Li X, Qiu R, 2016, Effect Mechanism of Atorvastatin Calcium Combined with Clopidogrel on Blood Lipid and Vascular Endothelial Relaxation Function in Patients with Unstable Angina Pectoris. China Medical Herald, 13(15): 162–165.
Wang X, 2019, Clinical Application Effect of Aspirin, Clopidogrel and Atorvastatin in the Treatment of Elderly Unstable Angina Pectoris. China Rural Health, 11(22): 33–34.
Li M, Cheng J, Du H, et al., 2019, The Effect of Compound Danshen Dripping Pills Combined with Clopidogrel in the Treatment of Unstable Angina Pectoris and Its Effect on Serum Levels of Nitric Oxide and Endothelin-1. Chinese Clinical Practical Medicine, 10(3): 16–20.
Liu J, Liao S, Huang Z, 2019, Efficacy and Safety Study of Aspirin, Clopidogrel Combined with Nadroparin in the Treatment of Patients with Unstable Angina Pectoris as Soon as Possible. China Practical Medicine, 14(27): 86–87.
Du S, 2019, Efficacy and Safety Evaluation of Clopidogrel Combined with Aspirin in the Treatment of Unstable Angina Pectoris. Chinese Medicine Guide, 17(22): 95–96.
Li H, Sun Y, Tan X, 2020, Effects of Different Doses of Clopidogrel Combined with Aspirin on Hemorheology, Platelet Aggregation Rate and Safety in Patients with Unstable Angina Pectoris. Contemporary Medicine, 26(1): 176–178.
Lin C, Guo C, Zhao L, et al., 2020, Comparative Study on the Efficacy and Safety of Ticagrelor and Clopidogrel in the Treatment of Unstable Angina Pectoris. Journal of Cardiovascular and Cerebrovascular Diseases of Integrated Traditional Chinese and Western Medicine, 18(2): 219–222.
Yu P, Shi R, Xu B, et al., 2021, Clinical Efficacy of Aspirin Combined with Clopidogrel in the Treatment of Unstable Angina Pectoris in Elderly Patients with Coronary Atherosclerotic Heart Disease. Chinese Journal of Clinicians, 49(12): 1434–1436.
Chen P, Jiang H, Qu X, et al., 2021, Efficacy of Tirofiban Hydrochloride Combined with Clopidogrel in the Treatment of Patients with Unstable Angina Pectoris and Its Influence on Electrocardiogram. Chinese Journal of Clinicians, 49(9): 1041–1043.
Wang S, 2018, The Effect of Clopidogrel Combined with Aspirin on Serum Inflammatory Factors and Cardiac Function in Elderly Patients with Unstable Angina Pectoris. Chinese Journal of Gerontology, 38(3): 529–531.
Song H, Ma F, 2020, Clinical Effectiveness Analysis of Simvastatin Combined with Clopidogrel in the Treatment of Unstable Angina Pectoris. Knowledge of Prevention and Treatment of Cardiovascular Diseases, 10(1): 17–18.
Wei M, 2020, Study on the Effect and Safety of Indobufen Combined with Clopidogrel in the Treatment of Unstable Angina Pectoris. Contemporary Medicine, 18(15): 82–84.
Hao Y, 2020, Clinical Analysis of Clopidogrel Combined with Aspirin in the Treatment of Patients with Unstable Angina Pectoris and Diabetes Mellitus. Chinese Medicine Guide, 18(6): 80–81.
Chen Y, Zu W, 2020, Comparison of the Clinical Efficacy of Ticagrelor and Clopidogrel in the Treatment of Unstable Angina Pectoris of Coronary Heart Disease. Chinese Medicine Guide, 18(21): 93–94.
Li Y, 2020, The Effect of Clopidogrel Combined with Aspirin on Platelet Aggregation and Inflammatory Response in Patients with Unstable Angina Pectoris. Clinical Medicine, 40(12): 109–111.